Evidence map›Paper›PMID 40091870›Full record

ArticleEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2025

Final kissing balloon dilatation in patients with coronary bifurcation lesions treated with an upfront provisional stenting strategy.

Ovidio De Filippo, Jeehoon Kang, Francesco Bruno, Young Bin Song, Salvatore Campagnuolo, Ki Hong Choi, Tineke H Pinxterhuis, Hyun Kuk Kim, Alessio Mattesini, Yun-Kyeong Cho and 26 more

Abstract read
In one paragraph

Article in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Impact of Strut Thickness for Patients Treated With Percutaneous Revascularization for Coronary Bifurcations: Insights From the BIFURCAT-ULTRA Registry.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Article
  2. Contemporary evidence in protected percutaneous coronary intervention: a case-based review.European heart journal supplements : journal of the European Society of Cardiology · 2026
    Article
  3. Article
  4. The First-in-Man Technique of Drug Eluting and Perfusion Therapy for Left Main Coronary Artery Disease.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Ovidio De FilippoDivision of Cardiology, Cardiovascular and Thoracic Department, A.O.U. Città della Salute e della Scienza, Turin, Italy.
Jeehoon KangDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea.
Francesco BrunoDivision of Cardiology, Cardiovascular and Thoracic Department, A.O.U. Città della Salute e della Scienza, Turin, Italy.
Young Bin SongDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Salvatore CampagnuoloDepartment of Medical Sciences, University of Turin, Turin, Italy.
Ki Hong ChoiDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Tineke H PinxterhuisDepartment of Cardiology, Thorax Centrum Twente, Medisch Spectrum Twente, Enschede, the Netherlands.
Hyun Kuk KimDepartment of Internal Medicine and Cardiovascular Center, Chosun University Hospital, University of Chosun College of Medicine, Gwangju, Republic of Korea.
Alessio MattesiniCardiologia Interventistica, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Yun-Kyeong ChoDivision of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, Republic of Korea.
Raffaele PiccoloDepartment of Advanced Biomedical Sciences, Division of Cardiology, University of Naples Federico II, Naples, Italy.
Hyun-Jong LeeDepartment of Cardiology, Department of Internal Medicine, Sejong General Hospital, Bucheon, Republic of Korea.
Wojciech WańhaCardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.
Bernardo CorteseFondazione Ricerca e Innovazione Cardiovascolare, Milan, Italy and DCB Academy, Milan, Italy.
Seung Hwan HanDepartment of Internal Medicine, Gachon University Gil Hospital, Incheon, Republic of Korea.
Leor PerlCardiology Department, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
Seung-Ho HurDivision of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, Republic of Korea.
Domenico TuttolomondoCardiology Unit, University Hospital of Parma, Parma, Italy.
Mario IannacconeDivision of Cardiology, Ospedale San Giovanni Bosco, Turin, Italy.
Woo Jung ChunDepartment of Internal Medicine, Samsung Changwon Hospital, Changwon, Republic of Korea.
Antonio GrecoAzienda Ospedaliero-Universitaria Policlinico "G. Rodolico-San Marco", University of Catania, Catania, Italy.
Attilio LeoneDepartment of Advanced Biomedical Sciences, Division of Cardiology, University of Naples Federico II, Naples, Italy.
Alessandra Truffa GiachetDivision of Cardiology, Ivrea Hospital, Ivrea, Italy.
Hyeon-Cheol GwonDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Giulio StefaniniDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Hyo-Soo KimDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea.
Javier EscanedHospital Clínico San Carlos IdISSC, Complutense University of Madrid and CIBER-CV, Madrid, Spain.
Antonino CarmeciDivision of Cardiology, Cardiovascular and Thoracic Department, A.O.U. Città della Salute e della Scienza, Turin, Italy.
Gianluca CampoCardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Italy.
Giuseppe PattiUniversity of Eastern Piedmont "Amedeo Avogadro", Novara, Italy.
Davide CapodannoAzienda Ospedaliero-Universitaria Policlinico "G. Rodolico-San Marco", University of Catania, Catania, Italy.
Clemens von BirgelenDepartment of Cardiology, Thorax Centrum Twente, Medisch Spectrum Twente, Enschede, the Netherlands.
Bon-Kwon KooDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea.
Gaetano Maria de FerrariDivision of Cardiology, Cardiovascular and Thoracic Department, A.O.U. Città della Salute e della Scienza, Turin, Italy.
Chang-Wook NamDivision of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, Republic of Korea.
Fabrizio D'AscenzoDivision of Cardiology, Cardiovascular and Thoracic Department, A.O.U. Città della Salute e della Scienza, Turin, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe impact of final kissing balloon inflation (FKB) in patients treated with an upfront provisional strategy for coronary bifurcation lesions is controversial.

aimsWe aimed to assess the impact of FKB on patient- and lesion-oriented outcomes in a large real-world cohort.

methodsThe ULTRA-BIFURCAT registry was obtained by patient-level merging the BIFURCAT and ULTRA registries. Pairs of patients were generated with propensity score matching (PSM). The primary outcome of interest was major adverse cardiac events (MACE) - a composite of all-cause death, myocardial infarction (MI), target lesion revascularisation (TLR) or stent thrombosis. A lesion-oriented composite outcome (LOCO) - a composite of target vessel MI (TVMI) or TLR - along with each single component of MACE represented the secondary outcomes. Subgroup analyses included the site of bifurcation (unprotected left main [ULM] vs non-ULM), side branch involvement (true bifurcation vs non-true bifurcation), side branch diameter and lesion length. Follow-up was censored at 800 days.

resultsA total of 5,607 patients undergoing a provisional stenting technique were selected for the present analysis. PSM generated 1,784 pairs. Between the matched patients with FKB versus no FKB, no significant difference in MACE was observed (9.0% vs 8.6%; p=0.68). FKB was associated with a lower rate of the LOCO (1.9% vs 2.9%; p=0.04) compared to the no FKB group, driven by lower rates of TVMI (0.2% vs 0.5%; p=0.03) and TLR (1.8% vs 2.6%; p=0.14). These results were confirmed in the subgroups of patients treated for bifurcations with side branches with a diameter >2.5 mm and for true coronary bifurcation lesions.

conclusionsAmong patients treated for coronary bifurcation lesions with provisional stenting, FKB had no significant impact on MACE but was associated with a mild reduction in the incidence of the LOCO.

Indexed as

Angioplasty, Balloon, CoronaryCoronary Artery DiseasePercutaneous Coronary InterventionStentsAgedCoronary AngiographyDrug-Eluting StentsFemaleHumansMaleMiddle AgedMyocardial InfarctionPropensity ScoreRegistriesTreatment Outcome

Identifiers

PMID40091870
PMCPMC11895841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.